(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPP1R3B mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:733420 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP1R3B mRNA CTD PMID:36331819 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of PPP1R3B mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO RGD:1344962 6480464 [Estradiol co-treated with Norethindrone Acetate] results in increased expression of PPP1R3B mRNA CTD PMID:22217510 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PPP1R3B mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PPP1R3B mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO RGD:733420 6480464 Estradiol results in decreased expression of PPP1R3B mRNA CTD PMID:19484750 17beta-estradiol decreases expression ISO RGD:1344962 6480464 Estradiol results in decreased expression of PPP1R3B mRNA CTD PMID:20106945 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:1344962 6480464 2 more ... CTD PMID:36804509 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733420 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R3B mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PPP1R3B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344962 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R3B mRNA CTD PMID:20106945 , PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R3B mRNA CTD PMID:20959002 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733420 6480464 Tetrachlorodibenzodioxin affects the expression of PPP1R3B mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1344962 6480464 Tetrachlorodibenzodioxin affects the expression of PPP1R3B mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PPP1R3B mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PPP1R3B mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1344962 6480464 Lactic Acid results in decreased expression of PPP1R3B mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 , PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1344962 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PPP1R3B mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PPP1R3B mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1344962 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PPP1R3B mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:733420 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PPP1R3B mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of PPP1R3B mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PPP1R3B mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:733420 6480464 Acrylamide results in decreased expression of PPP1R3B mRNA CTD PMID:35032568 aflatoxin B1 affects expression ISO RGD:1344962 6480464 Aflatoxin B1 affects the expression of PPP1R3B protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1344962 6480464 Aflatoxin B1 results in decreased methylation of PPP1R3B gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1344962 6480464 Aflatoxin B1 results in decreased expression of PPP1R3B mRNA CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:733420 6480464 Aflatoxin B1 results in decreased expression of PPP1R3B mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:1344962 6480464 Tretinoin results in increased expression of PPP1R3B mRNA CTD PMID:23724009 , PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PPP1R3B mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1344962 6480464 Antirheumatic Agents results in increased expression of PPP1R3B mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1344962 6480464 aristolochic acid I results in decreased expression of PPP1R3B mRNA CTD PMID:33212167 belinostat increases expression ISO RGD:1344962 6480464 belinostat results in increased expression of PPP1R3B mRNA CTD PMID:26272509 belinostat multiple interactions ISO RGD:1344962 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mRNA CTD PMID:27188386 benzo[a]pyrene affects methylation ISO RGD:1344962 6480464 Benzo(a)pyrene affects the methylation of PPP1R3B promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1344962 6480464 Benzo(a)pyrene results in decreased expression of PPP1R3B mRNA CTD PMID:32234424 benzo[a]pyrene multiple interactions ISO RGD:733420 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PPP1R3B mRNA] CTD PMID:22228805 benzo[a]pyrene increases expression ISO RGD:1344962 6480464 Benzo(a)pyrene results in increased expression of PPP1R3B mRNA CTD PMID:21871943 benzo[a]pyrene decreases expression ISO RGD:733420 6480464 Benzo(a)pyrene results in decreased expression of PPP1R3B mRNA CTD PMID:19770486 benzo[b]fluoranthene decreases expression ISO RGD:733420 6480464 benzo(b)fluoranthene results in decreased expression of PPP1R3B mRNA CTD PMID:26377693 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PPP1R3B mRNA CTD PMID:26496021 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPP1R3B mRNA CTD PMID:30816183 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PPP1R3B mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1344962 6480464 bisphenol A results in increased expression of PPP1R3B mRNA CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PPP1R3B mRNA CTD PMID:25181051 more ... bisphenol F increases expression ISO RGD:733420 6480464 bisphenol F results in increased expression of PPP1R3B mRNA CTD PMID:30951980 cadmium atom multiple interactions ISO RGD:1344962 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPP1R3B mRNA CTD PMID:35301059 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of PPP1R3B promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO RGD:1344962 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPP1R3B mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PPP1R3B mRNA CTD PMID:25993096 calcitriol increases expression ISO RGD:1344962 6480464 Calcitriol results in increased expression of PPP1R3B mRNA CTD PMID:16002434 carbon nanotube increases expression ISO RGD:733420 6480464 Nanotubes, Carbon results in increased expression of PPP1R3B mRNA CTD PMID:25620056 ciguatoxin CTX1B affects expression ISO RGD:733420 6480464 Ciguatoxins affects the expression of PPP1R3B mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:1344962 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PPP1R3B mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1344962 6480464 Cisplatin results in decreased expression of PPP1R3B mRNA CTD PMID:27392435 copper atom multiple interactions ISO RGD:1344962 6480464 [NSC 689534 binds to Copper] which results in increased expression of PPP1R3B mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1344962 6480464 [NSC 689534 binds to Copper] which results in increased expression of PPP1R3B mRNA CTD PMID:20971185 crocidolite asbestos increases expression ISO RGD:1344962 6480464 Asbestos, Crocidolite results in increased expression of PPP1R3B mRNA CTD PMID:18687144 CU-O LINKAGE increases expression ISO RGD:1344962 6480464 cupric oxide results in increased expression of PPP1R3B mRNA CTD PMID:22077320 cyclosporin A decreases expression ISO RGD:1344962 6480464 Cyclosporine results in decreased expression of PPP1R3B mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A decreases expression ISO RGD:733420 6480464 Cyclosporine results in decreased expression of PPP1R3B mRNA CTD PMID:19770486 dexamethasone multiple interactions ISO RGD:1344962 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PPP1R3B mRNA CTD PMID:28628672 dichloroacetic acid decreases expression ISO RGD:733420 6480464 Dichloroacetic Acid results in decreased expression of PPP1R3B mRNA CTD PMID:28962523 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of PPP1R3B mRNA CTD PMID:21161181 dioxygen increases expression ISO RGD:733420 6480464 Oxygen deficiency results in increased expression of PPP1R3B mRNA CTD PMID:20880076 dorsomorphin multiple interactions ISO RGD:1344962 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PPP1R3B mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1344962 6480464 entinostat results in increased expression of PPP1R3B mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1344962 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mRNA CTD PMID:27188386 epoxiconazole affects expression ISO RGD:733420 6480464 epoxiconazole affects the expression of PPP1R3B mRNA CTD PMID:35436446 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of PPP1R3B mRNA CTD PMID:30307764 fluoranthene multiple interactions ISO RGD:733420 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of PPP1R3B mRNA CTD PMID:28329830 furan increases methylation EXP 6480464 furan results in increased methylation of PPP1R3B gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of PPP1R3B mRNA CTD PMID:25539665 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PPP1R3B mRNA CTD PMID:33387578 hydrogen cyanide decreases expression ISO RGD:733420 6480464 Hydrogen Cyanide results in decreased expression of PPP1R3B mRNA CTD PMID:33914522 indometacin multiple interactions ISO RGD:1344962 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PPP1R3B mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:733420 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP1R3B mRNA CTD PMID:36331819 kenpaullone decreases expression EXP 6480464 kenpaullone results in decreased expression of PPP1R3B mRNA CTD PMID:17993264 methylmercury chloride decreases expression ISO RGD:1344962 6480464 methylmercuric chloride results in decreased expression of PPP1R3B mRNA CTD PMID:23179753 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of PPP1R3B mRNA CTD PMID:19638242 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of PPP1R3B mRNA CTD PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:1344962 6480464 N-Nitrosopyrrolidine results in decreased expression of PPP1R3B mRNA CTD PMID:32234424 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PPP1R3B mRNA CTD PMID:24136188 nickel dichloride increases expression ISO RGD:1344962 6480464 nickel chloride results in increased expression of PPP1R3B mRNA CTD PMID:21455298 niclosamide decreases expression ISO RGD:1344962 6480464 Niclosamide results in decreased expression of PPP1R3B mRNA CTD PMID:36318118 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PPP1R3B mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO RGD:1344962 6480464 methyleugenol results in decreased expression of PPP1R3B mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PPP1R3B mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PPP1R3B mRNA CTD PMID:25729387 panobinostat multiple interactions ISO RGD:1344962 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1344962 6480464 panobinostat results in increased expression of PPP1R3B mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:733420 6480464 Acetaminophen affects the expression of PPP1R3B mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1344962 6480464 Acetaminophen results in increased expression of PPP1R3B mRNA CTD PMID:22230336 paracetamol decreases expression ISO RGD:1344962 6480464 Acetaminophen results in decreased expression of PPP1R3B mRNA CTD PMID:21420995 more ... perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of PPP1R3B mRNA CTD PMID:19162173 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:733420 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP1R3B mRNA more ... CTD PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1344962 6480464 perfluorooctane sulfonic acid results in decreased expression of PPP1R3B mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PPP1R3B mRNA CTD PMID:19162173 permethrin decreases expression ISO RGD:733420 6480464 Permethrin results in decreased expression of PPP1R3B mRNA CTD PMID:30629241 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of PPP1R3B mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:733420 6480464 Phenobarbital results in decreased expression of PPP1R3B mRNA CTD PMID:19270015 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PPP1R3B mRNA CTD PMID:19162173 pirinixic acid decreases expression ISO RGD:733420 6480464 pirinixic acid results in decreased expression of PPP1R3B mRNA CTD PMID:23811191 potassium cyanide decreases expression ISO RGD:733420 6480464 Potassium Cyanide results in decreased expression of PPP1R3B mRNA CTD PMID:33914522 rac-lactic acid decreases expression ISO RGD:1344962 6480464 Lactic Acid results in decreased expression of PPP1R3B mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:733420 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PPP1R3B mRNA] CTD PMID:31298478 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PPP1R3B mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:1344962 6480464 Rotenone results in decreased expression of PPP1R3B mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1344962 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine decreases expression ISO RGD:733420 6480464 senecionine results in decreased expression of PPP1R3B protein CTD PMID:35357534 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of PPP1R3B mRNA CTD PMID:15967596 silicon dioxide decreases expression ISO RGD:1344962 6480464 Silicon Dioxide analog results in decreased expression of PPP1R3B mRNA CTD PMID:25895662 sodium arsenite increases stability ISO RGD:1344962 6480464 sodium arsenite results in increased stability of PPP1R3B mRNA CTD PMID:25493608 sodium arsenite decreases expression ISO RGD:1344962 6480464 sodium arsenite results in decreased expression of PPP1R3B mRNA CTD PMID:29301061 , PMID:34032870 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of PPP1R3B mRNA CTD PMID:25993096 testosterone decreases expression ISO RGD:1344962 6480464 Testosterone results in decreased expression of PPP1R3B mRNA CTD PMID:33359661 tetrachloromethane decreases expression ISO RGD:733420 6480464 Carbon Tetrachloride results in decreased expression of PPP1R3B mRNA CTD PMID:27339419 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PPP1R3B mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPP1R3B mRNA] CTD PMID:31150632 thimerosal decreases expression ISO RGD:1344962 6480464 Thimerosal results in decreased expression of PPP1R3B mRNA CTD PMID:27188386 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PPP1R3B mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide multiple interactions ISO RGD:733420 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PPP1R3B mRNA] CTD PMID:31298478 titanium dioxide increases expression ISO RGD:733420 6480464 titanium dioxide results in increased expression of PPP1R3B mRNA CTD PMID:31298478 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of PPP1R3B mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of PPP1R3B mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PPP1R3B mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1344962 6480464 trichostatin A results in increased expression of PPP1R3B mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1344962 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mRNA CTD PMID:27188386 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of PPP1R3B mRNA CTD PMID:30589522 triptonide affects expression ISO RGD:733420 6480464 triptonide affects the expression of PPP1R3B mRNA CTD PMID:33045310 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of PPP1R3B mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:733420 6480464 Valproic Acid affects the expression of PPP1R3B mRNA CTD PMID:17963808 valproic acid decreases expression ISO RGD:1344962 6480464 Valproic Acid results in decreased expression of PPP1R3B mRNA CTD PMID:23179753 , PMID:29154799 valproic acid affects expression ISO RGD:1344962 6480464 Valproic Acid affects the expression of PPP1R3B mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1344962 6480464 Valproic Acid results in increased expression of PPP1R3B mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1344962 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1344962 6480464 vorinostat results in increased expression of PPP1R3B mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1344962 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3B mRNA CTD PMID:27188386